Feldman EL, et al
Since Ozempic has gone viral, some doctors have been flooded with inquiries
Systemic side effects observed in retatrutide trials are broadly consistent with the GLP-1 receptor agonist class and include nausea, vomiting, diarrhoea, constipation, decreased appetite, and fatigue
External resources Anorgasmia following initiation of GLP-1 agonist, PMC Case Report International Society for Sexual Medicine, GLP-1 Agonists and Sexuality GLP-1 Receptor Agonists, Compulsive Behavior, and Libido, PMC Research GLP-1 Agonist Weight Loss Medications and Sexual Desire, Journal of Sexual Medicine For researchers committed to understanding the full picture of how GLP-1 medications affect female health, SeekPeptides provides evidence-based protocols, comprehensive guides, and a community of knowledgeable researchers navigating these exact questions with the depth and nuance they deserve